Gallium scintigraphy in patients with adult T-cell leukemia lymphoma. NLM AIDSLINE Important note: Information in this article was accurate in 1989. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


Gallium scintigraphy in patients with adult T-cell leukemia lymphoma.

Eur J Nucl Med. 1988;14(4):177-9. Unique Identifier : AIDSLINE MED/89005193
Hoshi H; Jinnouchi S; Harada K; Watanabe K; Department of Radiology, Miyazaki Medical College, Japan.

Abstract: Gallium scintigraphy was evaluated in 25 patients with adult T-cell leukemia lymphoma (ATLL). Anterior and posterior images were obtained at 72 h after administration of 3 mCi 67Ga-citrate using a gamma camera (Maxi-Camera 400 T, General Electric Co.) with a medium energy standard parallel hole collimator. Abnormally high accumulations were observed in 17 out of 25 cases (superficial lymph node, 8; hilar and mediastinal lymph node, 7; paraaortic lymph node, 2; lung, 9; liver, 1; bone, 1). There were 10 malignant lesions detected by 67Ga scintigraphy in 9 out of 17 cases (superficial lymph node, 1; hilar and mediastinal lymph node, 6; paraaortic lymph node, 1; liver, 1; bone, 1). White blood cell count and serum LDH levels were raised in patients with abnormally high accumulations of 67Ga. In conclusion, 67Ga scintigraphy seemed to be a useful examination to detect malignant lesions in patients with ATLL.
Keywords: Female Gallium Radioisotopes/*DIAGNOSTIC USE Human Leukemia-Lymphoma, T-Cell, Acute, HTLV-I-Associated/*RADIONUCLIDE IMAGING Lung/RADIONUCLIDE IMAGING Lung Neoplasms/RADIONUCLIDE IMAGING Lymph Nodes/RADIONUCLIDE IMAGING Male Middle Age JOURNAL ARTICLE

KWDfemalegalliumradioisotopes/KWDdiagnosticusehumanleukemia-lymphoma,t-cell,acute,htlv-i-associated/KWDradionuclideimaginglung/radionuclideimaginglungneoplasms/radionuclideimaginglymphnodes/radionuclideimagingmalemiddleagejournalarticle
890130
M8910489

Copyright © 1989 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1989. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1989. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .